https://www.ctvnews.ca/health/coronavirus/novavax-deliveries-arrive-in-canada-1.5843358
The Novavax vaccine differs from the Pfizer-BioNTech and Moderna vaccines in that it is a protein-based vaccine and not an mRNA vaccine.
The two-dose Nuvaxovid vaccine produced by the U.S. biotech firm Novavax showed 90 per cent effectiveness in protecting clinical trial participants from symptomatic COVID-19, and 100 per cent effectiveness in preventing severe disease, according to a press releasefrom the company.
https://www.ctvnews.ca/health/coronavirus/man-in-germany-gets-90-covid-19-shots-to-sell-forged-passes-1.5846273